Operation Warp-Pay: How 10b5-1 Plans Allowed Pfizer and Moderna Executives to Cash In

With Pfizer and Moderna’s COVID-19 vaccines in the headlines, the companies’ executive teams have also attracted attention because of the sizeable stock sales they benefitted from after positive trial developments were announced. Although the timing [...]

By |2021-04-08T14:50:41-07:00January 21, 2021|Blog|Comments Off on Operation Warp-Pay: How 10b5-1 Plans Allowed Pfizer and Moderna Executives to Cash In

Glass Lewis Submits Comment Letter to SEC on Proposed Amendments to Exemptions from the Proxy Rules for Proxy Voting Advice

Glass Lewis has submitted a comment letter regarding the United States Securities and Exchange Commission regarding the proposed Amendments to Exemptions from the Proxy Rules for Proxy Voting Advice. As a proxy advisor, Glass Lewis [...]

By |2021-04-08T14:51:18-07:00February 4, 2020|Blog, Regulatory Matters|Comments Off on Glass Lewis Submits Comment Letter to SEC on Proposed Amendments to Exemptions from the Proxy Rules for Proxy Voting Advice

Case Study: The AES Corporation’s No Action Reaction

When The AES Corporation managed to exclude a shareholder proposal that would have lowered the ownership threshold for calling a special meeting, it thought it had avoided a recurring headache. In the end though, disregarding [...]

By |2021-04-08T14:52:07-07:00October 29, 2018|Blog|Comments Off on Case Study: The AES Corporation’s No Action Reaction

ValueEdge Blog: More Bogus Anti-Shareholder Propaganda to Fuel the Upcoming SEC Proxy Roundtable

Nell Minow is Vice Chair of ValueEdge Advisors. Reposted with permission from the ValueEdge blog. The SEC’s roundtable on the proxy system is scheduled for next month, and so articles that look suspiciously like plants from [...]

By |2021-04-08T14:52:12-07:00October 11, 2018|Blog|Comments Off on ValueEdge Blog: More Bogus Anti-Shareholder Propaganda to Fuel the Upcoming SEC Proxy Roundtable

Glass Lewis Response To SEC Statement Regarding Staff Proxy Advisory Letters

The proxy advisor no-action letters, issued in 2004 to Egan-Jones and ISS, described the duty of investment advisers to ensure their proxy advisor(s) have the capacity and competency to adequately analyze proxy issues. While the [...]

By |2021-04-08T14:52:20-07:00September 14, 2018|Blog, Regulatory Matters|Comments Off on Glass Lewis Response To SEC Statement Regarding Staff Proxy Advisory Letters